Lift Life Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-07-2024
- Paid Up Capital ₹ 1.00 M
as on 16-07-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 45.63%
(FY 2023)
- Profit 4.76%
(FY 2023)
- Ebitda 10758.00%
(FY 2023)
- Net Worth -11.02%
(FY 2023)
- Total Assets 2.39%
(FY 2023)
About Lift Life Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Archana Verma and Bhushanendu Verma serve as directors at the Company.
- CIN/LLPIN
U74120UP2012PTC088275
- Company No.
088275
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Lift Life Biotech Private Limited offer?
Lift Life Biotech Private Limited offers a wide range of products and services, including Injectable Products, Pharmaceutical Injectables, Pain Reliever Gel, Diclofenac Diethylamine Gel, Mineral Supplement, Ferrous Ascorbate Tablet, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Vitamin & Multivitamin Injections, Methylcobalamin Injection.
Who are the key members and board of directors at Lift Life Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Verma  | Director | 16-May-2015 | Current |
| Bhushanendu Verma | Director | 02-Mar-2012 | Current |
Financial Performance of Lift Life Biotech.
Lift Life Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.63% increase. The company also saw a slight improvement in profitability, with a 4.76% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lift Life Biotech?
In 2023, Lift Life Biotech had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lift Life Biotech?
Lift Life Biotech has a workforce of 6 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lift Life Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lift Life Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
